Dr. Gary Wayne Abrams, MD

Dr. Abrams practices at Kresge Eye Institute in Detroit, Michigan.

Dr. Abrams' NPI, 1831136431, was assigned on June 1, 2006. Dr. Abrams graduated from University of Oklahoma College of Medicine in 1968. Dr. Abrams holds Michigan license 4301060220.

Dr. Abrams' primary practice is Kresge Eye Institute, at 4717 St Antoine St, Detroit, MI 48201 in Wayne County. The practice phone is (313) 577-8900.

Dr. Abrams' primary practice is Kresge Eye Institute in Detroit, Michigan. The medical group on file is Wayne Health. Dmand AI also links Dr. Abrams to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abrams practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Abrams' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Abrams is licensed in Michigan.

CMS data shows 409 Medicare services from Dr. Abrams across 3 procedure codes in 2024, for 80 Medicare patients. Medicare paid $22,696 for them. Every service was in an office.

CMS counts 80 Medicare patients who saw Dr. Abrams in 2026. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abrams' median patient age at 71, with 55% women.

In 2026, Dr. Abrams wrote 119 Medicare Part D claims for 27 patients. 71% of them were for generic drugs. CMS names the drug for 79 of them, across 4 drugs with 11 or more claims each, at $2,855 in total drug cost. In 2023, CMS named 99 claims across 4 drugs.

Dr. Abrams accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 84 papers to Dr. Abrams, published from 2005 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Breast Neoplasms, Retina and Cancer Survivors. Dr. Abrams has published most often in Retin Cases Brief Rep. Dr. Abrams' most frequent co-authors are Gary M. Abrams, MD, Jon D. Levine, MD and Bruce Cooper, MD.

Dmand AI links Dr. Abrams to 1 clinical trial.

CMS Open Payments shows 12 general payments to Dr. Abrams from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 97% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $156.

Dr. Abrams graduated from University of Oklahoma College of Medicine in 1968.